MassMutual Private Wealth & Trust’s Vanguard Health Care ETF VHT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12M | Sell |
40,007
-109
| -0.3% | -$30.3K | 0.31% | 71 |
|
|
2026
Q1 | $10.9M | Sell |
40,116
-947
| -2% | -$271K | 0.3% | 77 |
|
|
2025
Q4 | $11.8M | Sell |
41,063
-1,788
| -4% | -$500K | 0.3% | 77 |
|
|
2025
Q3 | $11.1M | Buy |
42,851
+908
| +2% | +$228K | 0.28% | 80 |
|
|
2025
Q2 | $10.4M | Buy |
41,943
+1,376
| +3% | +$340K | 0.28% | 84 |
|
|
2025
Q1 | $10.7M | Buy |
40,567
+1,529
| +4% | +$407K | 0.31% | 74 |
|
|
2024
Q4 | $9.9M | Buy |
39,038
+190
| +0.5% | +$51.2K | 0.28% | 86 |
|
|
2024
Q3 | $11M | Buy |
38,848
+822
| +2% | +$228K | 0.31% | 80 |
|
|
2024
Q2 | $10.1M | Buy |
38,026
+27
| +0.1% | +$7.08K | 0.31% | 79 |
|
|
2024
Q1 | $10.3M | Buy |
37,999
+17
| +0% | +$4.47K | 0.32% | 78 |
|
|
2023
Q4 | $9.52M | Buy |
37,982
+576
| +2% | +$136K | 0.32% | 75 |
|
|
2023
Q3 | $8.79M | Buy |
37,406
+158
| +0.4% | +$38.5K | 0.32% | 75 |
|
|
2023
Q2 | $9.12M | Buy |
37,248
+373
| +1% | +$90.7K | 0.33% | 77 |
|
|
2023
Q1 | $8.79M | Buy |
36,875
+1,091
| +3% | +$263K | 0.34% | 80 |
|
|
2022
Q4 | $8.88M | Buy |
35,784
+1,161
| +3% | +$281K | 0.37% | 74 |
|
|
2022
Q3 | $7.75M | Buy |
34,623
+96
| +0.3% | +$22.9K | 0.35% | 77 |
|
|
2022
Q2 | $8.13M | Sell |
34,527
-804
| -2% | -$194K | 0.35% | 74 |
|
|
2022
Q1 | $8.99M | Sell |
35,331
-3,838
| -10% | -$948K | 0.34% | 78 |
|
|
2021
Q4 | $10.4M | Buy |
39,169
+1,576
| +4% | +$402K | 0.39% | 70 |
|
|
2021
Q3 | $9.29M | Buy |
37,593
+1,255
| +3% | +$322K | 0.38% | 71 |
|
|
2021
Q2 | $8.98M | Buy |
36,338
+1,347
| +4% | +$322K | 0.38% | 73 |
|
|
2021
Q1 | $8M | Buy |
34,991
+2,470
| +8% | +$567K | 0.38% | 74 |
|
|
2020
Q4 | $7.28M | Buy |
32,521
+2,446
| +8% | +$523K | 0.37% | 70 |
|
|
2020
Q3 | $6.13M | Buy |
30,075
+1,901
| +7% | +$385K | 0.36% | 73 |
|
|
2020
Q2 | $5.43M | Buy |
28,174
+1,856
| +7% | +$348K | 0.35% | 69 |
|
|
2020
Q1 | $4.37M | Sell |
26,318
-3,756
| -12% | -$686K | 0.35% | 74 |
|
|
2019
Q4 | $5.77M | Buy |
30,074
+543
| +2% | +$97.4K | 0.36% | 73 |
|
|
2019
Q3 | $4.95M | Buy |
29,531
+1,139
| +4% | +$195K | 0.33% | 81 |
|
|
2019
Q2 | $4.94M | Sell |
28,392
-8,795
| -24% | -$1.48M | 0.34% | 78 |
|
|
2019
Q1 | $6.41M | Buy |
37,187
+8,331
| +29% | +$1.41M | 0.46% | 51 |
|
|
2018
Q4 | $4.63M | Buy |
28,856
+117
| +0.4% | +$19.8K | 0.4% | 61 |
|
|
2018
Q3 | $5.18M | Buy |
28,739
+2,483
| +9% | +$427K | 0.38% | 65 |
|
|
2018
Q2 | $4.18M | Buy |
26,256
+1,744
| +7% | +$275K | 0.33% | 73 |
|
|
2018
Q1 | $3.76M | Buy |
24,512
+3,428
| +16% | +$547K | 0.31% | 85 |
|
|
2017
Q4 | $3.25M | Buy |
21,084
+1,540
| +8% | +$236K | 0.27% | 95 |
|
|
2017
Q3 | $2.98M | Buy |
19,544
+4,019
| +26% | +$600K | 0.25% | 113 |
|
|
2017
Q2 | $2.29M | Buy |
+15,525
| New | +$2.19M | 0.2% | 129 |
|
Other funds holding VHT
AIA
AAG
CA
CMA
LFP
MAM
BI
TAM
DAS
MassMutual Private Wealth & Trust's VHT Position: Q2 2026 in Review
MassMutual Private Wealth & Trust reduced its Vanguard Health Care ETF (VHT) stake by 0.27% in Q2 2026, selling an estimated $30.3K and leaving 40,007 shares worth $12M. The position accounts for 0.31% of the portfolio, ranked #71.
MassMutual Private Wealth & Trust first reported a position in VHT in Q2 2017 and has held it in 37 quarters since. 212 funds tracked by Wall St. Rank hold VHT as of Q2 2026.
- MassMutual Private Wealth & Trust held 40,007 shares of Vanguard Health Care ETF worth $12M as of Q2 2026.
- MassMutual Private Wealth & Trust sold 109 Vanguard Health Care ETF shares in Q2 2026, an estimated $30.3K.
- Vanguard Health Care ETF made up 0.31% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #71 holding.
- MassMutual Private Wealth & Trust first reported a position in Vanguard Health Care ETF in Q2 2017 and has held it in 37 quarters since.
- 212 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.